Maha Qubain

Maha Qubain specializes in cell therapy process development and manufacturing. She began her career at Kite working on CAR-T manufacturing and optimization, then moved to MiNK Therapeutics to support CAR-iNKT development, and later contributed to allogeneic iNKT & γδ T-cell platform development at Appia Bio. BS: University of California, Los Angeles — Microbiology, Immunology & Molecular Genetics